Vitamin D Receptor in Cancer: Biological Functions, Mechanistic Insights, and Clinical Relevance

Ming Liang1, Shengjie Yin2, Yisheng Dai3

  • 1Department of Infection, Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.

PubMed

Insights

Vitamin D (VD) research is inconsistent due to complex Vitamin D Receptor (VDR) roles in cancer. Understanding VDR mechanisms is key to improving cancer treatment and VD

Area of Science:

  • Oncology
  • Molecular Biology
  • Endocrinology

Background:

  • Vitamin D (VD) research yields inconsistent biological role conclusions.
  • VD functions via the Vitamin D Receptor (VDR), a transcription factor regulating gene expression.
  • VDR expression and function in cancer biology show divergent findings, indicating complexity.

Purpose of the Study:

  • To review the association between VDR expression and cancer prognosis.
  • To elucidate the roles and mechanisms of VDR in cancer.
  • To explore VDR regulatory networks and translational implications in cancer therapy.

Main Methods:

  • Systematic review of existing literature.
  • Analysis of VDR expression via immunohistochemistry in relation to cancer prognosis.
  • Examination of VDR's roles, mechanisms, and regulatory networks in cancer.

Main Results:

  • Conflicting data exists on VDR expression and its association with cancer prognosis.
  • VDR plays complex roles in cancer biology, influencing gene expression and cellular pathways.
  • Multi-level regulatory networks govern VDR activity, impacting its therapeutic potential.

Conclusions:

  • Clarifying VDR's precise roles and mechanisms is crucial for cancer treatment optimization.
  • Resolving conflicting clinical evidence on VD's impact on cancer requires a deeper understanding of VDR.
  • Further research into VDR is essential for advancing VD-based cancer therapies.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.8K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.8K
Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
7.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K